Panitumumab in metastatic colorectal cancer

Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):10-1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / surgery
  • Epidermal Growth Factor / antagonists & inhibitors*
  • Fluorouracil / administration & dosage
  • Humans
  • Irinotecan
  • Leucovorin / administration & dosage
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Male
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage
  • Panitumumab

Substances

  • Antibodies, Monoclonal
  • Organoplatinum Compounds
  • Epidermal Growth Factor
  • Panitumumab
  • Irinotecan
  • Leucovorin
  • Fluorouracil
  • Camptothecin

Supplementary concepts

  • Folfox protocol